Such inhibitors may have applications in clinical indications of DDR1 and DDR2 overexpression or mutation , including lung cancer .
O O O O O O O O O B-GeneOrGeneProduct O B-GeneOrGeneProduct O O O O O B-DiseaseOrPhenotypicFeature I-DiseaseOrPhenotypicFeature O